Literature DB >> 12727838

Overexpression of high mobility group box 1 in gastrointestinal stromal tumors with KIT mutation.

Yon Rak Choi1, Hyunki Kim, Hyun Ju Kang, Nam-Gyun Kim, Jung Jin Kim, Kang-Sik Park, Young-Ki Paik, Hyun Ok Kim, Hoguen Kim.   

Abstract

Gain-of-function mutations of KIT are common genetic events in gastrointestinal stromal tumors (GISTs). To investigate the molecular characteristics of KIT mutations in GISTs, 20 GISTs (14 GISTs with KIT mutation and 6 GISTs without KIT mutation) were analyzed by two-dimensional electrophoresis and matrix-associated laser desorption ionization mass spectrophotometry-time of flight. Comparative analysis of the respective spot patterns on two-dimensional electrophoresis showed that HMGB1, an intranuclear protein that interacts with several transcription factors and plays a role in tumor metastasis after its secretion, was overexpressed in GISTs with KIT mutation. All of the 14 GISTs with KIT mutation, and only 2 of 6 GISTs without KIT mutation, revealed HMGB1 expression. Of the GISTs with KIT mutation, 12 (86%) showed strong expression of HMGB1, more than three times higher in intensity than the maximum observed in the 6 GISTs without KIT mutation by two-dimensional electrophoresis analysis. The overexpression of HMGB1 was further supported by Western blot analysis, and directly related to matrix metalloproteinase 2 overexpression. Our results indicate that the overexpression of HMGB1 is common in GISTs and is related to the KIT mutation, and that this may play a role in the tumorigenesis of GISTs because overexpressed HMGB1 could accelerate genes related to tumor growth and invasion.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12727838

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  44 in total

1.  A novel germline SDHB mutation in a gastrointestinal stromal tumor patient without bona fide features of the Carney-Stratakis dyad.

Authors:  Ricardo Celestino; Jorge Lima; Alexandra Faustino; Valdemar Máximo; António Gouveia; João Vinagre; Paula Soares; José Manuel Lopes
Journal:  Fam Cancer       Date:  2012-06       Impact factor: 2.375

2.  Role of microarray in cancer diagnosis.

Authors:  Hoguen Kim
Journal:  Cancer Res Treat       Date:  2004-02-29       Impact factor: 4.679

3.  Increased expression of high mobility group box 1 (HMGB1) is associated with an elevated level of the antiapoptotic c-IAP2 protein in human colon carcinomas.

Authors:  K Völp; M-L Brezniceanu; S Bösser; T Brabletz; T Kirchner; D Göttel; S Joos; M Zörnig
Journal:  Gut       Date:  2005-08-23       Impact factor: 23.059

4.  Improved detection of KIT exon 11 duplications in formalin-fixed, paraffin-embedded gastrointestinal stromal tumors.

Authors:  Jerzy Lasota; Bartosz Wasag; Sonja E Steigen; Janusz Limon; Markku Miettinen
Journal:  J Mol Diagn       Date:  2007-02       Impact factor: 5.568

5.  Plasma high-mobility group box 1 as an indicator of surgical stress.

Authors:  Atsushi Osoegawa; Tokujiro Yano; Takeharu Yamanaka; Tetsuzo Tagawa; Fumihiro Shoji; Ichiro Yoshino; Akinobu Taketomi; Hiroyuki Ito; Yoshihiro Kakeji; Yoshihiko Maehara
Journal:  Surg Today       Date:  2011-07-12       Impact factor: 2.549

6.  Aspirin's Active Metabolite Salicylic Acid Targets High Mobility Group Box 1 to Modulate Inflammatory Responses.

Authors:  Hyong Woo Choi; Miaoying Tian; Fei Song; Emilie Venereau; Alessandro Preti; Sang-Wook Park; Keith Hamilton; G V T Swapna; Murli Manohar; Magali Moreau; Alessandra Agresti; Andrea Gorzanelli; Francesco De Marchis; Huang Wang; Marc Antonyak; Robert J Micikas; Daniel R Gentile; Richard A Cerione; Frank C Schroeder; Gaetano T Montelione; Marco E Bianchi; Daniel F Klessig
Journal:  Mol Med       Date:  2015-06-18       Impact factor: 6.354

7.  Correlation of HMGB1 expression to progression and poor prognosis of adenocarcinoma and squamous cell/adenosquamous carcinoma of gallbladder.

Authors:  Zilu Shi; Qian Huang; Jian Chen; Pengcheng Yu; Xiaosong Wang; Hong Qiu; Yijie Chen; Yangyang Dong
Journal:  Am J Transl Res       Date:  2015-10-15       Impact factor: 4.060

8.  Downregulation of HMGB1 by miR-34a is sufficient to suppress proliferation, migration and invasion of human cervical and colorectal cancer cells.

Authors:  Karthik Subramanian Chandrasekaran; Anusha Sathyanarayanan; Devarajan Karunagaran
Journal:  Tumour Biol       Date:  2016-07-25

9.  HMGB1 promotes tumor progression and invasion through HMGB1/TNFR1/NF-κB axis in castration-resistant prostate cancer.

Authors:  Ae Ryang Jung; Ga Eun Kim; Mee Young Kim; U-Syn Ha; Sung-Hoo Hong; Ji Youl Lee; Sae Woong Kim; Yong Hyun Park
Journal:  Am J Cancer Res       Date:  2021-05-15       Impact factor: 6.166

10.  Life after death: targeting high mobility group box 1 in emergent cancer therapies.

Authors:  Z Sheng Guo; Zuqiang Liu; David L Bartlett; Daolin Tang; Michael T Lotze
Journal:  Am J Cancer Res       Date:  2013-01-18       Impact factor: 6.166

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.